The firm is pursuing regulatory clearance for multiple tests and is targeting growth in an attractive CLIA market, a move that will require new hires.
The institute is offering whole-genome sequencing starting at $2,800, which includes the sequencing and initial interpretation.
The deal will allow LifeLabs to perform Natera's Panorama NIPT in Canada and follows a prior agreement for LifeLabs to distribute the test in that country.
The microbial genetics analysis firm said in an SEC document that it plans to offer between 2.5 million units of stock and warrants at between $5.50 and $6.50 per unit.
The firms will collaborate on metabolite profiling using ImaBiotech's Multimaging technology and iTeos' animal models and tissue libraries.
In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.
The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.
The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.
An Australian study of personalized medicine has run into problems as it recruits patients.
This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.